Failure of dipyridamole (Persantin) in reducing the infarct size following experimental coronary occlusion.
D000818:Animals; D001011:Aorta; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects; D003331:Coronary Vessels; D004176:Dipyridamole / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004285:Dogs; D004562:Electrocardiography; D007275:Injections, Intravenous; D008026:Ligation; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology; D011312:Pressure; D013268:Stimulation, Chemical
D004176:Dipyridamole